Bolt Biotherapeutics Stock Widgets and Gadgets
BOLT Stock | USD 0.43 0.01 2.27% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- BOLT Bolt Biotherapeutics
- Latest Bolt Biotherapeutics Neutral Rating Reiterated at HC Wainwright
- BOLT 0.43 -0.01
- Low 0.43
- High 0.47
- Alpha -0.16
- Beta 0.45
- Return On Equity -0.74
- Return On Asset -0.33
- Operating Margin (8.87) %
- Current Valuation (5.85 M)
- Shares Outstanding 38.27 M
- Shares Owned By Insiders 5.08 %
- Shares Owned By Institutions 48.15 %
- Number Of Shares Shorted 24.33 K
- Price To Earning 36.55 X
- Price To Book 0.28 X
- Price To Sales 2.12 X
- Revenue 7.69 M
- Gross Profit (49.78 M)
- EBITDA (66.45 M)
- Net Income (63.12 M)
- Cash And Equivalents 176.34 M
- Cash Per Share 4.68 X
- Total Debt 25.21 M
- Debt To Equity 0.11 %
- Current Ratio 9.73 X
- Book Value Per Share 1.49 X
- Cash Flow From Operations (61.29 M)
- Short Ratio 0.24 X
- Earnings Per Share (1.65) X
- Target Price 1.13
- Number Of Employees 52
- Beta 0.94
- Market Capitalization 16.27 M
- Total Asset 99.63 M
- Retained Earnings (427.4 M)
- Working Capital 34.96 M
- Current Asset 53.49 M
- Current Liabilities 9.12 M
- Net Asset 99.63 M
- Accumulation Distribution 0.0851
- Daily Balance Of Power (0.25)
- Rate Of Daily Change 0.98
- Day Median Price 0.45
- Day Typical Price 0.44
- Market Facilitation Index 0.04
- Price Action Indicator (0.03)
- Period Momentum Indicator (0.01)
- Relative Strength Index 37.31
Market Snapshot Widget Example
DAX Index Germany | 22,462 0.96 | |
Taiwan Weighted Taiwan | 21,603 1.59 | |
PSI 20 Stock Portugal | 6,951 0.75 | |
CROBEX Croatia | 3,329 0.11 | |
Budapest SE Hungary | 91,416 1.41 | |
IDX 30 Jakarta Indonesia | 386.86 0.42 | |
ISEQ 20 Price Ireland | 1,760 1.45 | |
NYSE Comp USA | 19,270 1.35 | |
Tel Aviv 35 Israel | 2,461 0.89 | |
Coreshares Index Tracker South Afric | 1,108 1.95 | |
IPC MEXICO Mexico | 53,173 0.57 | |
KL Technology Malaysia | 50.27 1.32 | |
IBEX 35 Index Spain | 13,309 0.84 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,176 2.08 | |
SPASX Dividend Opportunities Australia | 1,661 0.80 | |
HNX 30 Vietnam | 502.01 1.15 | |
Bucharest BET-NG Romania | 1,262 0.07 | |
AMS Small Cap Netherlands | 1,381 0.78 | |
Oslo Exchange Mutual Norway | 1,463 1.34 | |
BEL Small Belgium | 8,418 0.15 | |
Basic Materials Brazil | 5,422 1.55 | |
Swiss Leader Price Switzerland | 2,074 0.42 | |
Fondo Mutuo ETF Chile | 1,563 0.48 | |
Athens General Comp Greece | 1,736 0.6 | |
Stock Exchange Of Thailand | 1,175 1.05 | |
PX Prague Stock Czech Repub | 2,119 1.22 | |
THE PHILIPPINE STOCK Philippines | 6,147 0.13 | |
WIG 30 Poland | 3,505 1.04 | |
BIST Electricity Turkey | 465.96 1.39 |
Investing Ideas
In addition to having Bolt Biotherapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Bolt Biotherapeutics
Compare Bolt Biotherapeutics To Peers
Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.